SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019694
Filing Date
2023-05-09
Accepted
2023-05-09 16:16:10
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ubx-20230331.htm   iXBRL 10-Q 2619593
2 EX-10.1 ubx-ex10_1.htm EX-10 110273
3 EX-10.2 ubx-ex10_2.htm EX-10 188299
4 EX-10.3 ubx-ex10_3.htm EX-10 51355
5 EX-10.4 ubx-ex10_4.htm EX-10 137673
6 EX-31.1 ubx-ex31_1.htm EX-31 21327
7 EX-31.2 ubx-ex31_2.htm EX-31 21274
8 EX-32.1 ubx-ex32_1.htm EX-32 21140
  Complete submission text file 0000950170-23-019694.txt   9922147

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ubx-20230331_pre.xml EX-101.PRE 362060
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ubx-20230331_lab.xml EX-101.LAB 493149
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ubx-20230331.xsd EX-101.SCH 65356
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ubx-20230331_cal.xml EX-101.CAL 50117
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ubx-20230331_def.xml EX-101.DEF 232385
63 EXTRACTED XBRL INSTANCE DOCUMENT ubx-20230331_htm.xml XML 1673115
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38470 | Film No.: 23902241
SIC: 2834 Pharmaceutical Preparations